Closure of Trading window: Unaudited Financial Results for the quarter ended on 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Terce Laboratories has informed BSE that its Board of Directors will meet on Wednesday, 4 February 2026 to consider and approve the unaudited standalone financial results for the third quarter and nine months ending 31 December 2025. As per the company's insider trading code, the trading window for dealing in shares will remain closed for all designated persons from 1 January 2026 to 6 February 2026 (both days inclusive). This is a routine compliance disclosure filed under SEBI Listing Regulations. No financial figures have been disclosed yet — those will come after the board meeting.
This is a standard regulatory filing with no direct impact on shareholders. Investors should note the trading window closure, meaning insiders cannot trade during this period. Watch for the actual Q3 results announcement on or after 4 February 2026 for any meaningful stock movement.